Ruzsa Zoltan, Wojtasik-Bakalarz Joanna, Nyerges Andras, Rakowski Tomasz, Kleczynski Pawel, Bartus Stanislaw
II Dept. of Cardiology, Jagiellonian University, Krakow, Poland.
J Invasive Cardiol. 2017 Oct;29(10):336-339.
The aim of this study was to assess the safety of the retrograde procedure with long-term follow-up of 86 patients after retrograde recanalization of the superficial femoral artery (SFA).
Chronic total occlusion (CTO) of SFAs occurs in >50% of the patient population with peripheral artery disease. The retrograde technique is an option for patients with unsuccessful antegrade percutaneous interventions, but data from long-term follow-up after retrograde recanalization are still limited.
The study included 86 patients (67% males), who underwent percutaneous retrograde recanalization. Major adverse cardiovascular or cerebrovascular events and major adverse peripheral events were assessed from long-term (47.5 ± 40 months) follow-up data.
Mean patient age was 64 ± 9 years. Retrograde puncture was successful in all cases. Procedural success rate was 93%. In-hospital observation showed vascular perforation/bleeding in 4.7%, proximal hematoma in 9.3%, distal hematoma in 4.7%, pseudoaneurysm in 1.2%, thrombosis in 1.2%, puncture-site bleeding in 3.5%, and local inflammation in 1.2%. Mortality rate was 6.98%. Target-vessel reintervention was needed in 20.9% of cases, and percutaneous transluminal angioplasty of another artery was done in 27% of cases. Amputation rate was 4.7%.
Long-term follow-up shows that retrograde recanalization is connected with a high rate of technical success and low percentage of reinterventions. Retrograde technique is safe and related to low complication rates; most complications were localized in nature.
本研究旨在通过对86例股浅动脉(SFA)逆行再通术后患者进行长期随访,评估逆行手术的安全性。
在周围动脉疾病患者中,超过50%的患者存在股浅动脉慢性完全闭塞(CTO)。逆行技术是顺行经皮介入治疗失败患者的一种选择,但逆行再通术后长期随访的数据仍然有限。
该研究纳入了86例接受经皮逆行再通术的患者(67%为男性)。通过长期(47.5±40个月)随访数据评估主要不良心血管或脑血管事件以及主要不良外周事件。
患者平均年龄为64±9岁。所有病例逆行穿刺均成功。手术成功率为93%。住院观察显示血管穿孔/出血占4.7%,近端血肿占9.3%,远端血肿占4.7%,假性动脉瘤占1.2%,血栓形成占1.2%,穿刺部位出血占3.5%,局部炎症占1.2%。死亡率为6.98%。20.9%的病例需要对靶血管进行再次干预,27%的病例对另一动脉进行了经皮腔内血管成形术。截肢率为4.7%。
长期随访表明,逆行再通技术成功率高,再次干预率低。逆行技术安全,并发症发生率低;大多数并发症为局部性。